Skip to main content
. 2022 Oct 25;41:314. doi: 10.1186/s13046-022-02523-x

Fig. 9.

Fig. 9

Schematic representation of this study. B3GALT4 overexpression promotes CXCL9 and CXCL10 expression and secretion via the inhibition of c-Met signaling in the lipid raft, accompanied by the downstream Akt/mTOR/IRF-1 signaling pathway. The secreted chemokines recruit CD8+ T lymphocytes to the tumor microenvironment. In particular, lipid raft inhibitor combined with anti-GD2 mAb significantly suppressed tumor growth in the 9464D-derived tumor xenografts in vivo